These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20370855)

  • 1. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
    van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma.
    Speeckaert R; van Geel N; Luiten RM; van Gele M; Speeckaert M; Lambert J; Vermaelen K; Tjin EP; Brochez L
    Anticancer Res; 2011 Nov; 31(11):3697-703. PubMed ID: 22110189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistological study of cutaneous lymphocytes in vitiligo.
    Badri AM; Todd PM; Garioch JJ; Gudgeon JE; Stewart DG; Goudie RB
    J Pathol; 1993 Jun; 170(2):149-55. PubMed ID: 8345407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of skin-homing cytotoxic T cells (CD8+ -CLA+) in patients with vitiligo.
    Antelo DP; Filgueira AL; Cunha JM
    Photodermatol Photoimmunol Photomed; 2011 Feb; 27(1):40-4. PubMed ID: 21198882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus.
    Yang Y; Li S; Zhu G; Zhang Q; Wang G; Gao T; Li C; Wang L; Jian Z
    J Dermatol Sci; 2017 Jul; 87(1):50-59. PubMed ID: 28385330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alopecia, halo nevi and vitiligo in a pediatric case of Turner's syndrome.
    Miura T; Yamamoto T
    J Dermatol; 2017 Feb; 44(2):217-219. PubMed ID: 27238352
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of granulysin expression in vitiligo and halo-nevus.
    Hlača N; Vičić M; Kaštelan M; Dekanić A; Prpić-Massari L
    Sci Rep; 2024 Jul; 14(1):16580. PubMed ID: 39020008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
    Palermo B; Campanelli R; Garbelli S; Mantovani S; Lantelme E; Brazzelli V; Ardigó M; Borroni G; Martinetti M; Badulli C; Necker A; Giachino C
    J Invest Dermatol; 2001 Aug; 117(2):326-32. PubMed ID: 11511311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune etiology of generalized vitiligo.
    Le Poole IC; Luiten RM
    Curr Dir Autoimmun; 2008; 10():227-43. PubMed ID: 18460889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo.
    Abdallah M; Abdel-Naser MB; Moussa MH; Assaf C; Orfanos CE
    Eur J Dermatol; 2003; 13(6):548-52. PubMed ID: 14721774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo occurring after halo formation around congenital melanocytic nevi.
    Kim HS; Goh BK
    Pediatr Dermatol; 2009; 26(6):755-6. PubMed ID: 20199462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.
    Steitz J; Wenzel J; Gaffal E; Tüting T
    Eur J Cell Biol; 2004 Dec; 83(11-12):797-803. PubMed ID: 15679123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halo congenital nevocellular nevi associated with extralesional vitiligo: a case series with review of the literature.
    Stierman SC; Tierney EP; Shwayder TA
    Pediatr Dermatol; 2009; 26(4):414-24. PubMed ID: 19689516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
    Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
    J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones.
    Musette P; Bachelez H; Flageul B; Delarbre C; Kourilsky P; Dubertret L; Gachelin G
    J Immunol; 1999 Feb; 162(3):1789-94. PubMed ID: 9973443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous onset of segmental vitiligo and a halo surrounding a congenital melanocytic naevus.
    Hofmann UB; Bröcker EB; Hamm H
    Acta Derm Venereol; 2009; 89(4):402-6. PubMed ID: 19688155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of FOXP3+ regulatory T cells in healthy human skin and autoimmune dermatoses.
    Terras S; Gambichler T; Moritz RK; Altmeyer P; Lambert J
    Int J Dermatol; 2014 Mar; 53(3):294-9. PubMed ID: 23968190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.
    Yee C; Thompson JA; Roche P; Byrd DR; Lee PP; Piepkorn M; Kenyon K; Davis MM; Riddell SR; Greenberg PD
    J Exp Med; 2000 Dec; 192(11):1637-44. PubMed ID: 11104805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.
    Wańkowicz-Kalińska A; van den Wijngaard RM; Tigges BJ; Westerhof W; Ogg GS; Cerundolo V; Storkus WJ; Das PK
    Lab Invest; 2003 May; 83(5):683-95. PubMed ID: 12746478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.